PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Diseases Unit, I. Department of Medicine, University Medical Center, Hamburg-Eppendorf, Germany.\', \'German Center for Infection Research (DZIF), Partner Site, Hamburg-Lübeck-Borstel-Riems, Germany.\', \'Department of Transfusion Medicine, University Medical Center, Hamburg-Eppendorf, Germany.\', \'Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States of America.\', \'Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, California, United States of America.\', \'Institute of Medical Microbiology, Virology and Hygiene, University Medical Center, Hamburg-Eppendorf, Germany.\', \'Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, California, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.ppat.1009842
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 34529740
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
?:title
  • Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all